Regulation - Research, Atripla

Filter

Current filters:

ResearchAtripla

Popular Filters

Gilead's Quad non-inferior to Atripla for HIV; Truvada objections

08-03-2012

US biotech firm Gilead Sciences (Nasdaq: GILD) yesterday announced full Phase III clinical trial results…

Anti-viralsAtriplaBiotechnologyGilead SciencesNorth AmericaQuadRegulationResearchTruvada

COMPANY SPOTLIGHT

Menarini

Back to top